Search results
Author(s):
Markus P Schlaich
,
Murray D Esler
Added:
3 years ago
The pathogenesis of primary hypertension is multifactorial. However, the sympathetic nervous system plays an important role in circulatory and metabolic control and has clearly been established as a major contributor to the development of hypertension, with blood pressure elevation being initiated and sustained by elevated sympathetic nervous activity. Increased sympathetic outflow to the heart…
View more
Author(s):
Markus P Schlaich
,
Murray D Esler
Added:
3 years ago
The pathogenesis of primary hypertension is multifactorial. However, the sympathetic nervous system plays an important role in circulatory and metabolic control and has clearly been established as a major contributor to the development of hypertension, with blood pressure elevation being initiated and sustained by elevated sympathetic nervous activity. Increased sympathetic outflow to the heart…
View more
Author(s):
Dominik Linz
,
Felix Mahfoud
,
Sebastian Ewen
,
et al
Added:
3 years ago
The sympathetic nervous system regulates cardiac output, blood pressure (BP), heart rate and volume, electrolyte balance and composition of body fluids. The afferent signals to the brain are regulated by mechanosensitive baroreceptors, volume sensors and chemoreceptors located in the vessels and in many other organs, particularly in the heart, kidney, lung, brain and muscles. Sympathetic nervous…
View more
Dagmara Hering
Job title: Professor
Author
Author(s):
Deepak L Bhatt
,
Anna Meta Dyrvig Kristensen
,
Manan Pareek
,
et al
Added:
3 years ago
Hypertension is an important contributor to global morbidity and mortality and is a major burden on healthcare systems.1,2 More than 20% of the world’s population has high blood pressure when defined by conventional criteria: systolic blood pressure ≥140 mmHg or diastolic blood pressure ≥90 mmHg.3,4 Even with therapeutic lifestyle and pharmacological measures, blood pressure remains poorly…
View more
Author(s):
Debbie L Cohen
,
Raymond R Townsend
Added:
3 years ago
Chronic kidney disease (CKD) is increasingly prevalent, with an estimated 26 million adults with CKD in the US.1 Hypertension is the most common comorbidity in chronic kidney disease. At least 85% of patients with stage 3 CKD or greater have hypertension, making parenchymal kidney disease the most common ‘secondary’ form of hypertension. Treatment of hypertension can often be challenging, as…
View more
tVNS in POTS
Author(s):
Praloy Chakraborty
,
Kassem Farhat
,
Lynsie Morris
,
et al
Added:
3 months ago
Article
Author(s):
Joost Daemen
,
Dagmara Hering
Added:
3 months ago
In light of the recent ESC clinical consensus statement on Renal Denervation (RDN), a significant development has occurred in the management of hypertension. The European Society of Hypertension (ESH) has officially endorsed Renal Denervation as a recommended treatment for hypertension. This marks a pivotal moment in the field of hypertension management.This broadcast features a compelling…
View more
Author(s):
Juan Tamargo
Added:
3 years ago
Chronic heart failure (HF) is a complex and progressive clinical syndrome resulting from any abnormality of cardiac structure or function. The American College of Cardiology Foundation/American Heart Association guideline defines HF as ‘a complex clinical syndrome that results from any structural or functional impairment of ventricular filling or ejection of blood’.1 The European Society of…
View more